Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 1.00 |
| ▸ | NPC1 | O15118 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | F2 | P00734 | 1/20 | 0.66 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.63 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.63 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.63 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.61 |
| ▸ | GRM5 | P41594 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL997866 | 0.90 | RAB9A (0.89) | RAB9ANPC1MEN1KMT2AF2 | |
| SCHEMBL29366822 | 0.90 | RAB9A (0.89) | RAB9ANPC1MEN1KMT2AF2 | |
| SCHEMBL16583895 | 0.88 | RAB9A (0.86) | RAB9ANPC1MEN1KMT2AF2 | |
| Hydrochloric Acid SCHEMBL27681799 | 0.88 | RAB9A (0.86) | RAB9ANPC1MEN1KMT2AF2 | |
| SCHEMBL7189774 | 0.88 | RAB9A (0.86) | RAB9ANPC1MEN1KMT2AF2 | |
| SCHEMBL29611667 | 0.86 | RAB9A (0.76) | RAB9ANPC1MEN1KMT2AF2 | |
| SCHEMBL10978860 | 0.85 | RAB9A (0.86) | RAB9ANPC1MEN1KMT2AF2 | |
| Benzoic Acid SCHEMBL8529424 | 0.85 | RAB9A (0.80) | RAB9ANPC1MEN1KMT2AF2 | |
| SCHEMBL22636483 | 0.85 | RAB9A (0.80) | RAB9ANPC1MEN1KMT2AF2 | |
| SCHEMBL5011704 | 0.85 | RAB9A (0.86) | RAB9ANPC1MEN1KMT2AF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030138376-A1 | Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form | H. LUNDBECK A/S (DK) | 2003-07-24 | — | — | US | disclosed |
| EP-1268051-A2 | DOSING FORM FOR REAGENTS, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND PRODUCTION OF SAID DOSING FORM | H. Lundbeck A/S (DK) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001068599-A2 | DOSING FORM FOR REAGENTS, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND PRODUCTION OF SAID DOSING FORM | H. LUNDBECK A/S (DK) | 2001-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030138376-A1 | Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form | ATIC, SET, SORD | RAB9A 4287/4885NPC1 3888/4885MEN1 349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.